Science Explorer Back to mapMap
Discussion
Company · Emeryville · United States

Zogenix (United States)

zogenix.com/c/companyROR OpenAlex
Research works
28
▼ 56% vs 2018-21
Citations
713
25.9 per fractional work
Top-10% rate
28.8%
all institutions 10.0%
Open access
49%
world 40%
International
29%
world 18%
Zogenix (United States)

Not ranked overall: Zogenix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Zogenix (United States) work in?

In all years, 55% of research at Zogenix (United States) is in Health Sciences, 19% in Physical Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (10%), Engineering (7%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 55.5% of its workMedicine: 15 fractional works · 54.6% of its workPediatrics, Perinatology and Child Health: 4 fractional works · 16.3% of its workPsychiatry and Mental health: 4 fractional works · 14.4% of its workAnesthesiology and Pain Medicine: 2 fractional works · 5.6% of its workOncology: 1 fractional works · 2.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.3% of its workPhysiology: 1 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.4% of its workPharmacology: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.6% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workOccupational Therapy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workDentistry: 0 fractional works · 0.3% of its workOral Surgery: 0 fractional works · 0.3% of its workPhysical Sciences: 5 fractional works · 19.3% of its workEngineering: 2 fractional works · 6.6% of its workBiomedical Engineering: 1 fractional works · 1.9% of its workControl and Systems Engineering: 0 fractional works · 1.5% of its workComputational Mechanics: 0 fractional works · 1.2% of its workMechanical Engineering: 0 fractional works · 1.0% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workMaterials Science: 1 fractional works · 3.9% of its workPolymers and Plastics: 0 fractional works · 1.4% of its workBiomaterials: 0 fractional works · 1.3% of its workMaterials Chemistry: 0 fractional works · 1.2% of its workMathematics: 1 fractional works · 3.6% of its workDiscrete Mathematics and Combinatorics: 0 fractional works · 1.2% of its workGeometry and Topology: 0 fractional works · 1.2% of its workMathematical Physics: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 1 fractional works · 2.2% of its workOrganic Chemistry: 0 fractional works · 1.4% of its workElectrochemistry: 0 fractional works · 0.6% of its workInorganic Chemistry: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 1.2% of its workProcess Chemistry and Technology: 0 fractional works · 1.2% of its workEnvironmental Science: 0 fractional works · 1.2% of its workPollution: 0 fractional works · 0.9% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workAtmospheric Science: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workLife Sciences: 5 fractional works · 16.9% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 9.8% of its workMolecular Biology: 2 fractional works · 6.6% of its workGenetics: 1 fractional works · 1.9% of its workMolecular Medicine: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workBiotechnology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 3.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.5% of its workCognitive Neuroscience: 0 fractional works · 0.7% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 2.2% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 1.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workToxicology: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 0.4% of its workImmunology: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 8.4% of its workPsychology: 1 fractional works · 4.9% of its workClinical Psychology: 1 fractional works · 3.5% of its workSocial Psychology: 0 fractional works · 1.2% of its workApplied Psychology: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 1.6% of its workLiterature and Literary Theory: 0 fractional works · 1.2% of its workVisual Arts and Performing Arts: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 1.3% of its workGender Studies: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.4% of its workDemography: 0 fractional works · 0.3% of its workEducation: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.5% of its workStrategy and Management: 0 fractional works · 0.5% of its workALL ITS WORKZogenix (UnitedStates)28fractional works, all years
Life Sciences17%Physical Sciences19%Health Sciences55%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine1554.6%
    2. Health Professions00.6%
    3. Dentistry00.3%
    1. Engineering26.6%
    2. Materials Science13.9%
    3. Mathematics13.6%
    4. Chemistry12.2%
    5. Chemical Engineering01.2%
    6. Environmental Science01.2%
    7. Earth and Planetary Sciences00.2%
    8. Computer Science00.2%
    9. Physics and Astronomy00.1%
    1. Biochemistry, Genetics and Molecular Biology39.8%
    2. Neuroscience13.6%
    3. Agricultural and Biological Sciences12.2%
    4. Pharmacology, Toxicology and Pharmaceutics00.9%
    5. Immunology and Microbiology00.4%
    1. Psychology14.9%
    2. Arts and Humanities01.6%
    3. Social Sciences01.3%
    4. Business, Management and Accounting00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.59× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 3.37× its world share, 0 worksNeuroscienceChemistry: 1.73× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.58× its world share, 0 worksEarth and Planetary …Medicine: 3.79× its world share, 4 worksMedicineArts and Humanities: 0.63× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.34× its world share, 0 worksBusiness, Management…Psychology: 0.36× its world share, 0 worksPsychologySocial Sciences: 0.37× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Medicine3.79×4 works
  2. Neuroscience3.37×0 works
  3. Chemistry1.73×0 works
  4. Biochemistry, Genetics and Molecular Biology1.59×0 works
  5. Arts and Humanities0.63×0 works
  6. Earth and Planetary Sciences0.58×0 works
  7. Social Sciences0.37×0 works
  8. Psychology0.36×0 works
  9. Business, Management and Accounting0.34×0 works
  10. Computer Science0.10×0 works

Who are the top researchers at Zogenix (United States)?

Ranked on the quality score, Gail M. Farfel lead among researchers whose main affiliation is Zogenix (United States).

  1. 1 Gail M. Farfel United States · #305,664 worldwide 3.8k citations · 58 works
All ranked researchers at Zogenix (United States)

What are the most cited papers from Zogenix (United States)?

The most cited paper from Zogenix (United States) is "Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial" (Lieven G. Lagae, Joseph E. Sullivan, Kelly G. Knupp et al., 2019), with 381 citations. Next come "Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens" (251) and "Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome" (136).

Most cited papers
#PaperReleasedCitations
1 Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial Lieven G. Lagae, Joseph E. Sullivan, Kelly G. Knupp et al. · The Lancet Open access Dec 2019 381
2 Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens Rima Nabbout, Arun Mistry, Sameer M. Zuberi et al. · JAMA Neurology Open access 2 Dec 2019 251
3 Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome Kelly G. Knupp, Ingrid Eileen Scheffer, Berten Ceulemans et al. · JAMA Neurology Open access 2 May 2022 136
4 Bioinspired Design Provides High‐Strength Benzoxazine Structural Adhesives Cody James Higginson, Katerina G. Malollari, Yunqi Xu et al. · Angewandte Chemie International Edition Open access 5 Jul 2019 134
5 Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients An‐Sofie Schoonjans, Bernard P. Paelinck, Fabienne Marchau et al. · European Journal of Neurology Open access 28 Oct 2016 107
All 59 most cited papers, with filters and sorting

Which keywords describe research at Zogenix (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antiepileptic Drugs, Inflammation, Surgery, Genetics, Classification, Epilepsy, Neurobiology and Seizures.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Antiepileptic Drugs5▲ 182×2 topics
  2. Inflammation4▲ 5.9×4 topics
  3. Genetics3▲ 15×2 topics
  4. Surgery3▲ 37×2 topics
  5. Classification3▲ 33×2 topics
  6. Epilepsy3▲ 92×2 topics
  7. Neurobiology3▲ 35×2 topics
  8. Seizures3▲ 154×1 topic
  9. Status Epilepticus3▲ 205×1 topic
  10. Cognitive Function2▲ 46×2 topics
  11. Oxidative Stress2▲ 4.1×4 topics
  12. Neurodevelopmental Disorders2▲ 47×2 topics
  13. Prenatal Exposure2▲ 154×1 topic
  14. Teratogenicity2▲ 103×1 topic
  15. Neurological Disorders2▲ 7.9×6 topics
  16. Clinical Trials1▲ 8.1×3 topics
  17. Neurodevelopmental Outcomes1▲ 22×4 topics
  18. Anesthesia1▲ 34×2 topics
  19. Drug Development1▲ 29×2 topics
  20. Epidemiology1◆ 0.97×9 topics
  21. Off-Label Drug Use1▲ 105×1 topic
  22. Pain Management1▲ 18×6 topics
  23. Pediatric Pharmacokinetics1▲ 105×1 topic
  24. Dexmedetomidine1▲ 85×1 topic
  25. Quality of Life1▲ 2.7×6 topics
  26. Sedation1▲ 46×1 topic

Which research topics does Zogenix (United States) publish most on?

By volume in 2022-now: Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, Drug Transport and Resistance Mechanisms and Neuroscience and Neuropharmacology Research.

Epilepsy research and tr…1Epilepsy research and treatment: 1 fractional worksPharmacological Effects …0Pharmacological Effects and Toxicity Studies: 0 fractional worksDrug Transport and Resis…0Drug Transport and Resistance Mechanisms: 0 fractional worksNeuroscience and Neuropharmacology Research: 0 fractional worksAcute Lymphoblastic Leukemia research: 0 fractional worksAnesthesia and Sedative Agents: 0 fractional worksNeonatal and fetal brain pathology: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksGenetics and Neurodevelopmental Disorders: 0 fractional worksElectrochemical Analysis and Applications: 0 fractional works
Psychiatry and Mental healthPediatrics, Perinatology and Child HealthOncologyCellular and Molecular Neuroscience5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Epilepsy research and treatment Psychiatry and Mental health 1 works
  2. 2 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
  3. 3 Drug Transport and Resistance Mechanisms Oncology 0 works
  4. 4 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
  5. 5 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
  6. 6 Anesthesia and Sedative Agents Anesthesiology and Pain Medicine 0 works
  7. 7 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  9. 9 Genetics and Neurodevelopmental Disorders Genetics 0 works
  10. 10 Electrochemical Analysis and Applications Electrochemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.4%not open50.6%

World: 40% of research is openly available.

with international co-authors28.9%domestic only71.1%

World: 18% is written across borders.

How has Zogenix (United States)'s research output changed?

Output in 2022-2025 was 56% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Zogenix (United States) as a percentage of every work published that year, 0.0000074% in 2024.

still counting0.000050%0.00010%0.00015%Zogenix (United States)0.000019% in 202520102020

Fractional works of Zogenix (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Emeryville

All research institutions in Emeryville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Zogenix (United States). Posts are plain text and can be reported.